OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
WIN site inhibition disrupts a subset of WDR5 function
Andrew J. Siladi, Jing Wang, Andrea C. Florian, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Andrew J. Siladi, Jing Wang, Andrea C. Florian, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Showing 24 citing articles:
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma
Kelly Mitchell, Samuel A. Sprowls, Sonali Arora, et al.
Genes & Development (2023) Vol. 37, Iss. 3-4, pp. 86-102
Open Access | Times Cited: 32
Kelly Mitchell, Samuel A. Sprowls, Sonali Arora, et al.
Genes & Development (2023) Vol. 37, Iss. 3-4, pp. 86-102
Open Access | Times Cited: 32
WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think
April M. Weissmiller, Stephen W. Fesik, William P. Tansey
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 274-274
Open Access | Times Cited: 8
April M. Weissmiller, Stephen W. Fesik, William P. Tansey
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 274-274
Open Access | Times Cited: 8
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2
M. Vogt, Nevenka Dudvarski Stanković, Yiliam Cruz Garcia, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1509-1528
Open Access | Times Cited: 5
M. Vogt, Nevenka Dudvarski Stanković, Yiliam Cruz Garcia, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1509-1528
Open Access | Times Cited: 5
Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges
Sarah Gold, Ali Shilatifard
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access | Times Cited: 5
Sarah Gold, Ali Shilatifard
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access | Times Cited: 5
Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models
Kevin B. Teuscher, Somenath Chowdhury, Kenneth M. Meyers, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 22
Kevin B. Teuscher, Somenath Chowdhury, Kenneth M. Meyers, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 22
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5
Yanran Chen, Haomiao Su, Jianing Zhao, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113145-113145
Open Access | Times Cited: 10
Yanran Chen, Haomiao Su, Jianing Zhao, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113145-113145
Open Access | Times Cited: 10
Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies
Christian T. Meyer, Brianna N. Smith, Jing Wang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 35
Closed Access | Times Cited: 3
Christian T. Meyer, Brianna N. Smith, Jing Wang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 35
Closed Access | Times Cited: 3
Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 9
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 9
WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy
Emanuele Mocciaro, Roberto Giambruno, Stefano Micheloni, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 10, pp. 5144-5161
Open Access | Times Cited: 8
Emanuele Mocciaro, Roberto Giambruno, Stefano Micheloni, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 10, pp. 5144-5161
Open Access | Times Cited: 8
WDR5 Binding to Histone Serotonylation Is Driven by an Edge–Face Aromatic Interaction with Unexpected Electrostatic Effects
Christopher R. Travis, Hanne C. Henriksen, Jake R. Wilkinson, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 2
Christopher R. Travis, Hanne C. Henriksen, Jake R. Wilkinson, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 2
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer
Francesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Francesca Citron, I-Lin Ho, Chiara Balestrieri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Crystal structures of DCAF1-PROTAC-WDR5 ternary complexes provide insight into DCAF1 substrate specificity
Mark Mabanglo, Brian C. Wilson, Mahmoud Noureldin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Mark Mabanglo, Brian C. Wilson, Mahmoud Noureldin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research
Lize Cai, Bin Liu, Yufei Cao, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 5
Lize Cai, Bin Liu, Yufei Cao, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 5
Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors
Kevin B. Teuscher, Jonathan J. Mills, Jianhua Tian, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16783-16806
Closed Access | Times Cited: 4
Kevin B. Teuscher, Jonathan J. Mills, Jianhua Tian, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16783-16806
Closed Access | Times Cited: 4
Decoding the therapeutic landscape of alpha-linolenic acid: a network pharmacology and bioinformatics investigation against cancer-related epigenetic modifiers
Amrita Ulhe, Nidhi Sharma, Akanksha Mahajan, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-26
Closed Access | Times Cited: 4
Amrita Ulhe, Nidhi Sharma, Akanksha Mahajan, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-26
Closed Access | Times Cited: 4
Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
(2024)
Open Access
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
(2024)
Open Access
Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
eLife (2024) Vol. 12
Open Access
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
eLife (2024) Vol. 12
Open Access
Crystal structures of DCAF1-PROTAC-WDR5 ternary complexes provide insight into DCAF1 substrate specificity
Mark Mabanglo, Brian C. Wilson, Mahmoud Noureldin, et al.
Research Square (Research Square) (2024)
Open Access
Mark Mabanglo, Brian C. Wilson, Mahmoud Noureldin, et al.
Research Square (Research Square) (2024)
Open Access
Enhancing the Predictive Power of Machine Learning Models through a Chemical Space Complementary DEL Screening Strategy
Yanrui Suo, Qian Xu, Zhaoping Xiong, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18969-18980
Closed Access
Yanrui Suo, Qian Xu, Zhaoping Xiong, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18969-18980
Closed Access
WD repeat domain 5 (WDR5) inhibitors: a patent review (2016-present)
Jesse A. Coker, Shaun R. Stauffer
Expert Opinion on Therapeutic Patents (2024) Vol. 35, Iss. 1, pp. 31-45
Closed Access
Jesse A. Coker, Shaun R. Stauffer
Expert Opinion on Therapeutic Patents (2024) Vol. 35, Iss. 1, pp. 31-45
Closed Access
Single-Molecule Observation of Competitive Protein–Protein Interactions Utilizing a Nanopore
Jiaxin Sun, Antun Skanata, Liviu Movileanu
ACS Nano (2024)
Open Access
Jiaxin Sun, Antun Skanata, Liviu Movileanu
ACS Nano (2024)
Open Access
Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma
Kelly Mitchell, Sajina Shakya, Sonali Arora, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Kelly Mitchell, Sajina Shakya, Sonali Arora, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
(2023)
Open Access
Gregory C. Howard, Jing Wang, Kristie L. Rose, et al.
(2023)
Open Access
